M&A

These are six recent updates around payer mergers and acquisitions reported by Becker's since Jan. 12:

CVS Health has reported $4.2 billion in 2022 profit and said it will acquire primary care company Oak Street Health in an all-cash deal worth $10.6 billion.

The Federal Trade Commission is not expected to challenge UnitedHealth Group's acquisition of home health firm LHC Group, Seeking Alpha reported Jan. 31, citing a CTFN report. 

The Federal Trade Commission is reviewing UnitedHealth Group's planned purchase of home health firm LHC Group under a "potential vertical harm theory," Seeking Alpha reported Jan. 26, citing traders and a Capitol Forum report.

Elevance Health expects to add 1.6 million members and $4.5 billion in revenue from its acquisition of Blue Cross and Blue Shield of Louisiana, according to a Jan. 25 earnings call with investors. 

Elevance Health will acquire Blue Cross and Blue Shield of Louisiana, adding the Baton Rouge-based payer's 1.9 million members to its Anthem Blue Cross brand. 

Centene has completed its divestiture of Magellan Specialty Health to healthcare administration company Evolent Health. 

The U.K.'s Competition and Markets Authority is investigating UnitedHealth Group's proposed acquisition of the health technology firm EMIS Group, Seeking Alpha reported Jan. 20. 

Sentara Healthcare has finalized its acquisition of nonprofit health plan AvMed.

From the merging of two payers to multibillion-dollar acquisitions, these are seven M&A updates involving payers reported by Becker's since Nov. 17: